Enhanced production of farnesol by Candida albicans treated with four azoles

114Citations
Citations of this article
80Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

The dimorphic fungus Candida albicans excretes farnesol, which is produced enzymatically from the sterol biosynthetic intermediate farnesyl pyrophosphate. Inhibition of C. albicans by four azole antifungals, fluconazole, ketoconazole, miconazole, and clotrimazole, caused elevated farnesol production (10- to 45-fold). Furthermore, farnesol production occurs in both laboratory strains and clinical isolates (J. M. Hornby et al., Appl. Environ. Microbiol. 67:2982-2992, 2001) of C. albicans.

Cite

CITATION STYLE

APA

Hornby, J. M., & Nickerson, K. W. (2004). Enhanced production of farnesol by Candida albicans treated with four azoles. Antimicrobial Agents and Chemotherapy, 48(6), 2305–2307. https://doi.org/10.1128/AAC.48.6.2305-2307.2004

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free